Search Results 351-360 of 17324 for hba1c

  1. Study To Assess Safety And Efficacy Of GKT137831 In Patients With Primary Biliary Cholangitis Receiving Ursodeoxycholic Acid - Mayo Clinic

    The purpose of this study is to assess the safety and efficacy of GKT13783 in patients with Primary Biliary Cholangitis (PBC) who are taking a stable dose of ...

  2. Phase 1/2a Clinical Trial Of PR001 (LY3884961) In Patients With Parkinson's Disease With At Least One GBA1 Mutation (PROPEL)

    Poorly controlled/not adequately managed diabetes (Screening glycosylated hemoglobin [HbA1C] ≥ 7%);; History of unstable angina, myocardial infarction ...

  3. Licensed technology - Biliary Epigenetics and Regenerative Medicine: Robert C. Huebert

    The Biliary Epigenetics and Regenerative Medicine Lab of Robert C. Huebert, M.D., at Mayo Clinic has developed a transformed sinusoidal endothelial cell ...

  4. A Study To Evaluate The Effectiveness And Safety Of BG00011 In Participants With Idiopathic Pulmonary Fibrosis (SPIRIT) - Mayo Clinic

    The primary purpose of this study is to evaluate the effectiveness of BG00011 compared with placebo in participants with Idiopathic Pulmonary Fibrosis (IPF).

  5. Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D) - Mayo Clinic

    The purpose of this multi-center event-driven study in participants with anemia associated with chronic kidney disease (CKD) to evaluate the safety and efficacy ...

  6. Eosinophils in Insulin Sensitivity in Humans - Mayo Clinic

    These data will be innovative, and of great clinical importance in the era of FDA-approved biologic drugs treating many eosinophilic-driven diseases. These ...

  7. Ipilimumab Or High-Dose Interferon Alfa-2b In Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed By Surgery - Mayo Clinic

    Monoclonal antibodies, such as ipilimumab, can block tumor growth in different ways. Some block the ability of tumor cells to grow and spread. Others find tumor ...

  8. Gastroenterology and Hepatology - Clinical trials

    The purpose of this study is to evaluate EUS-nCLE as an imaging biomarker and PCL fluid DNA analysis as a molecular biomarker for the management of pancreatic ...

  9. https://www.mayoclinic.org/spanish_patient_consumer_recipe.xml

  10. Daratumumab in Primary Antiphospholipid Syndrome (DARE-APS) - Mayo Clinic

    Poorly controlled diabetes mellitus, defined as hemoglobin A1c (HbA1c) ≥ 8.0%. Concomitant malignancy or history of malignancy, except adequately treated ...